The Online Investor
Grocery & Drug Stores M&A image Grocery & Drug Stores M&A » By The Online Investor Staff, updated Thu., May. 6, 5:05 PM Recent mergers and acquisitions in the Grocery & Drug Stores M&A category.

Slide #5. Rite Aid Corporation RediClinic

Acquirer: Rite Aid Corporation (NYSE:RAD)
Acquiree: RediClinic
Details: Rite Aid Corporation (NYSE:RAD) announced today it has acquired Houston-based RediClinic, one of the nation's leading operators of retail clinics. RediClinic currently operates 30 clinics in the greater Houston, Austin and San Antonio areas. Through the acquisition, RediClinic will operate as a wholly owned subsidiary of Rite Aid. Details of the transaction were not disclosed.

Rite Aid provides an array of whole being health products and services. Co. reports its business in two main segments: Co.'s Retail Pharmacy Segment, which consists of Rite Aid stores and Health Dialog, a provider of healthcare coaching and disease management services to health plans and employers; and Pharmacy Services Segment, which consists of Elixir, its mid-market national pharmacy benefits manager (PBM), which provides a suite of PBM offerings including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication and pharmacy discount programs. Elixir also provides prescription discount programs.

RAD SEC Filing Email Alerts Service

Open the RAD Page at The Online Investor »

Company Name: 
Rite Aid Corp
Grocery & Drug Stores
Number of ETFs Holding RAD: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 

Open the RAD Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Hold (2.00 out of 4)
0th percentile
(ranked lower than approx. 100% of all stocks covered)

Analysts' Target Price:
RAD Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Grocery & Drug Stores M&A - Slide 5 of 48 Page |

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.